NOVN.CH

97.19

+0.51%↑

NOVN.CH

97.19

+0.51%↑

NOVN.CH

97.19

+0.51%↑

NOVN.CH

97.19

+0.51%↑

NOVN.CH

97.19

+0.51%↑

Search

Sonova Holding AG

Fechado

SetorSaúde

255.8 1.07

Visão Geral

Variação de preço das ações

24h

Atual

Mín

254.8

Máximo

256

Indicadores-chave

By Trading Economics

Rendimento

209M

Vendas

199M

2B

P/E

Médio do Setor

28.077

51.198

EPS

3.5

Rendimento de Dividendos

1.73

Margem de lucro

11.379

Funcionários

18,335

EBITDA

93M

510M

Recomendações

By TipRanks

Recomendações

Vender

Previsão para 12 meses

-0.85% downside

Dividendos

By Dow Jones

Rendimento de Dividendos

Médio do Setor

1.73%

2.40%

Estatísticas de Mercado

By TradingEconomics

Capitalização de Mercado

-2.6B

15B

Abertura anterior

254.73

Fecho anterior

255.8

Sentimento de Notícias

By Acuity

50%

50%

166 / 380 Ranking em Healthcare

Sonova Holding AG Gráfico

O desempenho passado não é um indicador confiável de resultados futuros.

Notícias Relacionadas

10 de set. de 2024, 10:08 UTC

Grandes Movimentos do Mercado

Hearing Aid Stocks Drop After Apple Adds Health Features to AirPods

Comparação entre Pares

Variação de preço

Sonova Holding AG Previsão

Preço-alvo

By TipRanks

-0.85% parte inferior

Previsão para 12 meses

Média 254.22 CHF  -0.85%

Máximo 310 CHF

Mínimo 189 CHF

Com base em 10 analistas de Wall Street que oferecem metas de preço de 12 meses para Sonova Holding AG - Dist nos últimos 3 meses.

Consenso de Avaliação

By TipRanks

Vender

10 ratings

0

Comprar

6

Manter

4

Vender

Sentimento

By Acuity

166 / 380 Ranking em Saúde

Sentimento de Notícias

Neutral

Volatilidade

Abaixo da média

Volume de Notícias (RCV)

Abaixo da média

Informação Financeira

Custos administrativos e de venda

Custos Operacionais

Lucro antes de imposto

Vendas

Custo das vendas

Lucro bruto sobre vendas

Despesa com juros da dívida

EBITDA

Resultado Operacional

$

Sobre Sonova Holding AG

Sonova Holding AG manufactures and sells hearing care solutions for adults and children in the United States, Europe, the Middle East, Africa, and the Asia Pacific. It operates through two segments, Hearing Instruments and Cochlear Implants segments. The Hearing Instruments segments engages in the design, development, manufacture, distribution, and service of hearing instruments and related products, as well as wireless headsets, speech-enhanced hearables, and audiophile headphones under the Phonak, Unitron, Hansaton, and Sennheiser brand names; and audiological care services under the AudioNova, Audium, Audition Santé, Boots Hearingcare, Connect Hearing, Geers, Hansaton, Lapperre, Schoonenberg, and Triton Hearing brands. The Cochlear Implants segment is involved in the design, development, manufacture, distribution, and service of hearing implants and related products under the Advanced Bionics brand. The company sells its products through independent distributors; and provides hearing care services through a network of stores and clinics. The company was formerly known as Phonak Holding AG and changed its name to Sonova Holding AG in August 2007. The company was founded in 1947 and is headquartered in Stäfa, Switzerland.